No Detail Found!

Evaluation, Comparison and Correlation of the Disease Activity and Damage Index among Patients of SLE with Healthy Controls through Echocardiography

Author(s)
Syed Muhammad Kashif Department of Medicine, Dow University of Health Sciences, Karachi, Sindh-Pakistan
Iftikhar Haider Naqvi Department of Medicine, Dow University of Health Sciences, Karachi, Sindh-Pakistan
Muhammad Tanveer Alam Department of Medicine, Dow University of Health Sciences, Karachi, Sindh-Pakistan
Beenish Imam Department of Cardiology, Dow University of Health Sciences, Karachi, Sindh-Pakistan
Muneeba Khan Department of Cardiology, Dow University of Health Sciences, Karachi, Sindh-Pakistan
Darshan Kumar Department of Medicine, Dow University of Health Sciences, Karachi, Sindh-Pakistan
Abstract
OBJECTIVE: To assess and compare echocardiographic findings in SLE patients with healthy controls and their correlation with disease activity and damage index. METHODOLOGY: This cross-sectional study was undertaken in the Department of Medicine, Civil Hospital Karachi, an affiliated hospital of Dow University of Health Sciences (DUHS) Karachi, Pakistan, from January to July 2023. Forty-one patients with SLE and Thirty-nine healthy controls were enrolled, undergoing echocardiographic analysis for cardiovascular complications with the clinical and biochemical profile. Statistical differences among groups were assessed using the Chi-square test for qualitative variables and the independent sample t-test for quantitative variables. The correlation between disease severity and cardiovascular events was determined by Pearson correlation. P = 0.05 was measured as statistically significant. RESULTS: The most common valvular abnormality was mitral regurgitation (48.7%), then tricuspid regurgitation (21.9%), aortic regurgitation (17.7%), mitral stenosis (2.4%) and mitral valve prolapse (4.8%) in SLE, Left ventricular internal diameter end diastole [p 0.001], Intraventricular septal wall thickness, and end-diastolic left ventricular internal diameter end-systole [p 0.002] were found statistically significant among the groups. Left ventricular posterior wall end-diastole [p < 0.00001] and pulmonary artery systolic pressure [p < 0.00001] were also substantial among groups. Lupus nephritis positively correlated to ejection fraction (r=0.00013, p 0.56). CONCLUSION: Cardiovascular complications are frequently reported in SLE, as assessed by echocardiographic findings. SLE severity is related to echocardiographic changes, and SLE with secondary Antiphospholipid syndrome (APS) significantly affects renal, haematological, and echocardiographic parameters.
Publication Details
Page(s) 343-349
Published Journal: Journal of Liaquat University of Medical and Health Sciences, Volume: 23, Issue: 04, Year: 2024

Request the full text from PASTIC

Keywords
echocardiography, Systemic lupus erythematosus, Lupus Nephritis, Antiphospholipid syndrome, SLE, Valvular heart diseases
References
Vaillant Justiz,Goyal AA,Varacallo A,M A,Island (FL): StatPearls Publishing A . .. Systemic Lupus Erythematosus. [Updated 2023 Aug, 4 : .
Drosos GC,Vedder D,Houben E,Boekel L,Atzeni F,Badreh S .2022 .EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome. Ann Rheum Dis, 10(6) : 221733-79.
Vavlukis M,Pop-Gjorcevab D,Poposka L,Sandevska E,Kedev S. Myocardial .2021 .Infarction in Systemic Lupus Erythematosus-the Sex-Specific Risk Profile. Curr Pharm Des, 10(29) : 3221-8.
Semalulu T,Tago A,Zhao K,Tselios K. Managing Cardiovascular K .2023 .Risk in Systemic Lupus Erythematosus: Considerations for the Clinician. Immunotargets Ther, 10 : 175-86.
Garg S,Bartels CM,Bao G,Helmick CG,Drenkard C,Lim SS .2023 .Timing and Predictors of Incident Cardiovascular Disease in Systemic Lupus Erythematosus: Risk Occurs Early and Highlights Racial Disparities. J Rheumatol, 10(1) : 84-92.
Kostopoulou M,Nikolopoulos D,Parodis I,Bertsias G .2020 .Cardiovascular Disease in Systemic Lupus Erythematosus: Recent Data on Epidemiology, Risk Factors and Prevention. Curr Vasc Pharmacol, 10(6) : 549-65.
Bello N,Meyers KJ,Workman J,Hartley L,McMahon M .2023 .Cardiovascular events and risk in patients with systemic lupus erythematosus: Systematic literature review and meta-analysis. Lupus, 10(3) : 325-41.
Jha SB,Rivera AP,Monar GV,Islam H,Puttagunta SM,Islam R .2022 .Systemic lupus erythematosus and cardiovascular disease. Cureus, 10(2) : .
Li D,Yoshida K,Feldman CH,Speyer C,Barbhaiya M,Guan H .2020 .Initial disease severity, cardiovascular events and all-cause mortality among patients with systemic lupus erythematosus. Rheumatology (Oxford), 10(3) : 495-504.
Gullo AL,Rodríguez-Carrio J,Gallizzi R,Imbalzano E,Squadrito G,Mandraffino G .2020 .Speckle tracking echocardiography as a new diagnostic tool for an assessment of cardiovascular disease in rheumatic patients. Prog Cardiovasc Dis, 03(3) : 327-40.
Zoccali C,Mark PB,Sarafidis P,Agarwal R,Adamczak M,Bueno de Oliveira R M .2023 .Diagnosis of cardiovascular disease in patients with chronic kidney disease. Nat Rev Nephrol, 10(11) : 4-46.
Barber MR,Drenkard C,Falasinnu T,Hoi A,Mak A,Kow NY .2021 .Global epidemiology of systemic lupus erythematosus. Nat Rev Rheumatol, 10(9) : 1-32.
Aringer M,Johnson SR .2021 .Systemic lupus erythematosus classification and diagnosis. Rheum Dis Clin North Am, 04(3) : 501-11.
Johnson SR,Gladman DD,Brunner HI,Isenberg D,Clarke AE,Barber MR .2023 .Evaluating the construct of damage in systemic lupus erythematosus. Arthritis Care Res (Hoboken), 10(5) : 998-1006.
Popescu BA,Stefanidis A,Fox KF,Cosyns B,Delgado V,Di Salvo V .2020 .Training, competence, and quality improvement in echocardiography: the European Association of Cardiovascular Imaging Recommendations: update 2020. Eur Heart J Cardiovasc Imaging, 10(12) : 1305-19.
Zhao LL,Takeuchi T,Avihingsanon Y,Yu XQ,Lapid EA,Lugue-Lizardo LR .2013 .Overview of Lupus Nephritis Management Guidelines and Perspective from Asia. Int J Rheum Dis, 10(6) : 12212-185X.
Zhang H,Yang C,Gao F,Hu S,Ma H .2022 .Evaluation of left ventricular systolic function in patients with systemic lupus erythematosus using ultrasonic layer-specific strain technology and its association with cardiovascular events: a long-term follow-up study. Cardiovasc Ultrasound, 10 : 25.
Diaz‐Gallo LM,Oke V,Lundström E,Elvin K,Ling Wu Y,Eketjäll S .2022 .Four systemic lupus erythematosus subgroups, defined by autoantibodies status, differ regarding HLA‐DRB1 genotype associations and immunological and clinical manifestations. ACR Open Rheumatol, 10(1) : 27-39.
Dabit JY,Valenzuela-Almada MO,Vallejo-Ramos S,Duarte-García A .2021 .Epidemiology of antiphospholipid syndrome in the general population. Curr Rheumatol Rep, 10(12) : 85.
Leone P,Cicco S,Prete M,Solimando AG,Susca N,Crudele L .2020 .Early echocardiographic detection of left ventricular diastolic dysfunction in patients with systemic lupus erythematosus asymptomatic for cardiovascular disease. Clin Exp Med, 10(1) : 8-19.
Gegenava T,Gegenava M,Steup-Beekman GM,Huizinga TW,Bax JJ,Delgado V .2020 .Left ventricular systolic function in patients with systemic lupus erythematosus and its association with cardiovascular events. J Am Soc Echocardiogr, 04(9) : 1116-22.
Hussain K,Gauto-Mariotti E,Cattoni HM,Arif AW,Richardson C,Manadan A .2021 .A meta-analysis and systematic review of valvular heart disease in systemic lupus erythematosus and its association with antiphospholipid antibodies. J Clin Rheumatol, 10(8) : e525-32.
Ming Wang TK,Chan N,Khayata M.,Cardiovascular Manifestations M. .2022 .Outcomes in Systemic Lupus Erythematosus: An Eight-Year Single Center Experience in the United States. Angiology, 10 : 877-86.
Venturelli V,Abrantes AM,Rahman A,Isenberg DA .2024 .The impact of antiphospholipid antibodies/ antiphospholipid syndrome on systemic lupus erythematosus. Rheumatology (Oxford), 10 : SI72-85.
Liang H,Ma C,Chen X .2022 .Case report: Mitral valve replacement for Libman-Sacks endocarditis and cerebral embolism of primary antiphospholipid syndrome. Front Cardiovasc Med, 985111 : 985111.
Attuquayefio S,Doku A,Dey D,Agyekum F,Akumiah FK,Kweki AG .2023 .Cardiac Abnormalities in Relation to the Disease Activity Index Among Systemic Lupus Erythematosus Patients in a Tertiary Hospital: A Cross-Sectional Study. Cureus, 10(11) : .
Abdelrahman W,Sakr SA,Gohar N. .2022 .Impact of antiphospholipid syndrome on disease characteristics and outcome in patients with systemic lupus erythematosus. Egypt Rheumatol, 11 : 67-72.
Sevim E,Zisa D,Andrade D,Sciascia S,Pengo V,Tektonidou MG .2022 .Characteristics of patients with antiphospholipid antibody positivity in the APS ACTION International Clinical Database and Repository. Arthritis Care Res (Hoboken), 10(2) : 324-35.
0

Citations

0

Downloads

39

Views